BrainsWay Ltd. (BWAY)
USD 8.78
(-3.3%)
USD 8.78
(-3.3%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -10.32 Million USD | 78.09% |
| 2022 | -47.09 Million USD | -191.29% |
| 2021 | -16.16 Million USD | 2.21% |
| 2020 | -16.53 Million USD | 22.24% |
| 2019 | -21.26 Million USD | -246.54% |
| 2018 | -6.13 Million USD | 47.93% |
| 2017 | -11.78 Million USD | -40.87% |
| 2016 | -8.36 Million USD | 25.51% |
| 2015 | -11.22 Million USD | 34.28% |
| 2014 | -17.08 Million USD | -60.4% |
| 2013 | -10.65 Million USD | -143.46% |
| 2012 | -4.37 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -43.76 Million USD | -286.56% |
| 2024 Q1 | -8.17 Million USD | -23.22% |
| 2023 Q1 | -39.28 Million USD | 16.58% |
| 2023 FY | -10.32 Million USD | 78.09% |
| 2023 Q4 | -10.32 Million USD | 73.52% |
| 2023 Q2 | -38.31 Million USD | 2.48% |
| 2023 Q3 | -38.97 Million USD | -1.72% |
| 2022 Q4 | -47.09 Million USD | 4.58% |
| 2022 FY | -47.09 Million USD | -191.29% |
| 2022 Q2 | -52.17 Million USD | -269.9% |
| 2022 Q1 | -14.1 Million USD | 12.75% |
| 2022 Q3 | -49.35 Million USD | 5.41% |
| 2021 Q2 | -15.59 Million USD | 73.24% |
| 2021 Q1 | -58.28 Million USD | -252.53% |
| 2021 FY | -16.16 Million USD | 2.21% |
| 2021 Q3 | -14.98 Million USD | 3.93% |
| 2021 Q4 | -16.16 Million USD | -7.9% |
| 2020 Q4 | -16.53 Million USD | -4.69% |
| 2020 Q2 | -17.61 Million USD | 1.98% |
| 2020 Q3 | -15.79 Million USD | 10.34% |
| 2020 Q1 | -17.96 Million USD | 15.48% |
| 2020 FY | -16.53 Million USD | 22.24% |
| 2019 Q3 | -23.74 Million USD | 13.4% |
| 2019 FY | -21.26 Million USD | -246.54% |
| 2019 Q2 | -27.41 Million USD | -485.87% |
| 2019 Q1 | -4.67 Million USD | 23.73% |
| 2019 Q4 | -21.26 Million USD | 10.45% |
| 2018 FY | -6.13 Million USD | 47.93% |
| 2018 Q4 | -6.13 Million USD | 8.38% |
| 2018 Q3 | -6.69 Million USD | 13.17% |
| 2018 Q2 | -7.71 Million USD | 26.95% |
| 2018 Q1 | -10.55 Million USD | 10.4% |
| 2017 FY | -11.78 Million USD | -40.87% |
| 2017 Q1 | -7.22 Million USD | 13.67% |
| 2017 Q2 | -6.63 Million USD | 8.07% |
| 2017 Q3 | -5.85 Million USD | 11.77% |
| 2017 Q4 | -11.78 Million USD | -101.16% |
| 2016 Q1 | -11.33 Million USD | -0.98% |
| 2016 FY | -8.36 Million USD | 25.51% |
| 2016 Q4 | -8.36 Million USD | 18.7% |
| 2016 Q3 | -10.28 Million USD | -0.55% |
| 2016 Q2 | -10.23 Million USD | 9.75% |
| 2015 Q3 | -11.55 Million USD | 11.18% |
| 2015 Q2 | -13 Million USD | 77.24% |
| 2015 Q1 | -57.15 Million USD | -234.56% |
| 2015 FY | -11.22 Million USD | 34.28% |
| 2015 Q4 | -11.22 Million USD | 2.81% |
| 2014 Q4 | -17.08 Million USD | 5.91% |
| 2014 Q2 | -22.57 Million USD | 1.72% |
| 2014 FY | -17.08 Million USD | -60.4% |
| 2014 Q3 | -18.15 Million USD | 19.56% |
| 2014 Q1 | -22.96 Million USD | -115.66% |
| 2013 Q2 | -4.91 Million USD | -28.34% |
| 2013 Q1 | -3.83 Million USD | 12.41% |
| 2013 Q3 | -5.13 Million USD | -4.47% |
| 2013 Q4 | -10.65 Million USD | -107.3% |
| 2013 FY | -10.65 Million USD | -143.46% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | -4.37 Million USD | 0.0% |
| 2012 Q4 | -4.37 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 138.106% |
| Cerus Corporation | 84.35 Million USD | 112.234% |
| Envoy Medical, Inc. | -3.81 Million USD | -170.582% |
| electroCore, Inc. | -9.95 Million USD | -3.666% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -101.366% |
| IceCure Medical Ltd | -9.93 Million USD | -3.886% |
| Inogen, Inc. | -103.56 Million USD | 90.036% |
| OrthoPediatrics Corp. | -9.26 Million USD | -11.363% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -183.439% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 21.204% |
| MaxCyte, Inc. | -27.76 Million USD | 62.828% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -100.853% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -1692.392% |
| Orthofix Medical Inc. | 96.44 Million USD | 110.701% |
| PAVmed Inc | 29.08 Million USD | 135.481% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 39.076% |
| RxSight, Inc. | -6.68 Million USD | -54.491% |
| Sight Sciences, Inc. | -102.71 Million USD | 89.953% |
| SI-BONE, Inc. | 5.72 Million USD | 280.388% |
| TELA Bio, Inc. | -3.94 Million USD | -161.332% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 118.004% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 3031.818% |
| Acutus Medical, Inc. | 12.27 Million USD | 184.046% |
| Talis Biomedical Corporation | -57.06 Million USD | 81.915% |
| Spectral AI, Inc. | -3.5 Million USD | -194.773% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 78.512% |
| CVRx, Inc. | -59.95 Million USD | 82.787% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 620.123% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 907.741% |
| Bioventus Inc. | 372.51 Million USD | 102.77% |
| Venus Concept Inc. | 74.3 Million USD | 113.889% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | -1.355% |
| LivaNova PLC | 62.53 Million USD | 116.504% |
| 908 Devices Inc. | -115.09 Million USD | 91.034% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 103.218% |
| Nemaura Medical Inc. | 9.92 Million USD | 203.98% |
| NeuroPace, Inc. | 54.33 Million USD | 118.993% |
| LENSAR, Inc. | -18.31 Million USD | 43.644% |
| Apyx Medical Corporation | -5.15 Million USD | -100.349% |
| Cutera, Inc. | 288.3 Million USD | 103.58% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 237.325% |
| BioSig Technologies, Inc. | 262 Thousand USD | 4038.931% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 76.454% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | -12.186% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.734% |
| Axonics, Inc. | -77.19 Million USD | 86.631% |
| Outset Medical, Inc. | 67.67 Million USD | 115.248% |
| IRIDEX Corporation | -4.28 Million USD | -140.672% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 94.203% |
| IRadimed Corporation | -47.71 Million USD | 78.373% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -241.044% |
| INVO Bioscience, Inc. | 8.45 Million USD | 222.114% |
| Telesis Bio, Inc. | 32.63 Million USD | 131.622% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -312.448% |
| Varex Imaging Corporation | 316.9 Million USD | 103.257% |
| Quipt Home Medical Corp. | 81.73 Million USD | 112.626% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -270.956% |
| Pulmonx Corporation | -42.36 Million USD | 75.637% |
| Dynatronics Corporation | 6.2 Million USD | 266.343% |
| Modular Medical, Inc. | -8.04 Million USD | -28.326% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -140.168% |
| Semler Scientific, Inc. | -57.13 Million USD | 81.936% |
| InMode Ltd. | -135.39 Million USD | 92.378% |
| Bruker Corporation | 891.3 Million USD | 101.158% |
| Cytosorbents Corporation | 4.18 Million USD | 346.771% |
| DexCom, Inc. | 2.02 Billion USD | 100.509% |
| Align Technology, Inc. | -840.47 Million USD | 98.772% |
| Viveve Medical, Inc. | -13.81 Million USD | 25.288% |
| ZimVie Inc. | 450.41 Million USD | 102.291% |
| Movano Inc. | -5.86 Million USD | -75.929% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 92.325% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -1692.392% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 620.123% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 102.892% |
| Profound Medical Corp. | -18.17 Million USD | 43.23% |
| Insulet Corporation | 798.1 Million USD | 101.293% |
| enVVeno Medical Corporation | -2.21 Million USD | -365.284% |
| Surmodics, Inc. | -12.01 Million USD | 14.1% |
| iCAD, Inc. | -21.2 Million USD | 51.341% |
| Nuwellis, Inc. | -2.81 Million USD | -266.087% |
| Biotricity, Inc. | 23.09 Million USD | 144.689% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 111.02% |
| Aethlon Medical, Inc. | -4.5 Million USD | -129.249% |
| InspireMD, Inc. | -8.04 Million USD | -28.278% |
| PAVmed Inc. | 29.08 Million USD | 135.481% |
| BIOLASE, Inc. | 11.34 Million USD | 190.973% |
| Beyond Air, Inc. | 6.22 Million USD | 265.677% |
| FONAR Corporation | -14.66 Million USD | 29.63% |
| AxoGen, Inc. | 32.26 Million USD | 131.984% |
| Vivani Medical, Inc. | 42 Thousand USD | 24671.429% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 3.171% |
| Inari Medical, Inc. | -7.16 Million USD | -44.114% |
| UFP Technologies, Inc. | 40.77 Million USD | 125.31% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 436.307% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -116.293% |
| Tenon Medical, Inc. | -1.25 Million USD | -722.311% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -35.682% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 13.469% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.465% |
| Sintx Technologies, Inc. | 905 Thousand USD | 1240.331% |
| NanoVibronix, Inc. | -3.27 Million USD | -214.826% |
| Quanterix Corporation | -132.95 Million USD | 92.238% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -270.956% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 53.856% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 101.369% |
| TransMedics Group, Inc. | 121.13 Million USD | 108.519% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 60.581% |
| NeuroMetrix, Inc. | -1.49 Million USD | -592.12% |
| Hyperfine, Inc. | -75.61 Million USD | 86.353% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 106.781% |
| Biomerica, Inc. | -3.38 Million USD | -204.874% |
| Bone Biologics Corporation | -3.02 Million USD | -240.98% |
| AVITA Medical, Inc. | -26.23 Million USD | 60.658% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -461.354% |
| Silk Road Medical, Inc | 64.42 Million USD | 116.019% |